Anti-Aging Gene Therapy

Dr. Adeel explains how activating specific pathways through gene therapy can combat aging's hallmarks. The upcoming phase two trial in Canada aims to study the effects on sarcopenia, osteopenia, and inflammatory markers in individuals aged 30 to 80. Backed by renowned investors, the therapy shows promise in revolutionizing gene therapies with minimal adverse effects.